Chronic Obstructive Pulmonary Disease (COPD)

References

Citations

1. Staton GW (2004). Chronic obstructive diseases of the lung. In DC Dale, DD Federman, eds., Scientific American Medicine, section 14, chap. 3. New York: WebMD.

2. Lundbäck B, et al. (2003). Not 15 but 50% of smokers develop COPD?—Report from the Obstructive Lung Disease in Northern Sweden Studies. Respiratory Medicine, 97(2): 115–122.

3. Heath JM (2000). Chronic obstructive pulmonary disease. In RE Rakel, ed., Saunders Manual of Medical Practice, 2nd ed., pp. 184–186. Philadelphia: W.B. Saunders.

4. American Thoracic Society/European Respiratory Society (2003). ATS/ERS: Standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency. American Journal of Respiratory and Critical Care Medicine, 168(7): 820–822.

5. Burns P, et al. (2003). Management of peripheral arterial disease in primary care. BMJ, 326(7389): 584–588.

6. Poole PJ, et al. (2005). Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews (2). Oxford: Update Software.

7. Barnes PJ (2000). Chronic obstructive pulmonary disease. New England Journal of Medicine, 343(4): 269–280.

8. Kerstjens H, et al. (2005). Chronic obstructive pulmonary disease. Clinical Evidence (13): 1923-1947.

9. Calverley P, et al. (2003). Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial. Lancet, 361: 449–456.

10. Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2005). Executive summary (updated 2005). In Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available online: http://www.goldcopd.com/GuidelinesResources.asp?I1=2&I2=0.

Other Works Consulted

• American Thoracic Society (2004). Standards for the diagnosis and management of patients with COPD. Available online: http://www.thoracic.org/COPD.

• Donohue FG, et al. (2002). A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest, 122(1): 47–55.

• Ferguson GT (2000). Recommendations for the management of COPD. Chest, 117: 23S–28S.

Go to previous section	Go to top of page	Go to next section
Author:	Lila Havens Robin Parks, MS	Last Updated: June 16, 2006
Medical Review:	Renée M. Crichlow, MD - Family Medicine Kathleen Romito, MD - Family Medicine Ken Y. Yoneda, MD - Pulmonology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.